Newsroom
Of five articles listed among the Journal of Clinical Microbiology’s “Top Cited” collection from the last two years, three included Mayo Clinic authors with papers focused on SARS-CoV-2.
This week on the podcast, Elitza Theel, Ph.D., director of Mayo Clinic’s Infectious Diseases Serology Laboratory, joins "Answers From the Lab" with Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Theel discuss antibody testing for COVID-19, including why this testing is done and when it’s most useful.
The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.
Representing Mayo Clinic at the event, Dr. William Morice contributed his expertise and experience as leaders from around the world redoubled their commitment to end the COVID-19 pandemic.
In the wake of the CDC withdrawing its emergency use authorization request for a coronavirus PCR test, social media posts claimed the action signaled that the tests were flawed. Dr. Matthew Binnicker explains why those claims are false.
Mayo Clinic Laboratories reaches patients around the globe. Alumni magazine highlights this work as it details the labs' international strategy.
Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory in Mayo Clinic’s Division of Clinical Microbiology, considers the prospects for COVID-19 this fall as the traditional influenza season ramps up.
Elitza Theel, Ph.D., director of Mayo Clinic’s Infectious Disease Serology Lab was featured in a discussion on NBC News about COVID-19 antibody tests.
In May and June 2021, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.
In April 2021, Mayo Clinic Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Dr. Guenzel, a fellow in Laboratory Genetics and Genomics at Mayo Clinic, is the recipient of this award for his publication “The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.”